Endurant Capital Management LP Teva Pharmaceutical Industries LTD Transaction History

Endurant Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$8.36 - $11.37 $6.37 Million - $8.67 Million	762,264 New	762,264 $6.75 Million
Q3 2022 Nov 14, 2022	SELL	$6.86 - $11.95 $1.92 Million - $3.35 Million	-280,603 Reduced 61.02%	179,226 $1.45 Million
Q2 2022 Aug 15, 2022	BUY	$7.38 - $10.4 $3.39 Million - $4.78 Million	459,829 New	459,829 $3.46 Million
Q1 2019 May 15, 2019	SELL	$15.58 - $20.01 $1.15 Million - $1.48 Million	-73,884 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$14.59 - $23.84 $1.08 Million - $1.76 Million	73,884 New	73,884 $1.14 Million
Q4 2017 Feb 14, 2018	SELL	$11.23 - $19.1 $203,633 - $346,340	-18,133 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$15.41 - $32.17 $279,429 - $583,338	18,133	18,133 $319,000

626

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $23.2B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Endurant Capital Management LP with notifications on news.